US20030204067A1 - Materials and methods for the purification of polyelectrolytes, particularly nucleic acids - Google Patents
Materials and methods for the purification of polyelectrolytes, particularly nucleic acids Download PDFInfo
- Publication number
- US20030204067A1 US20030204067A1 US10/436,813 US43681303A US2003204067A1 US 20030204067 A1 US20030204067 A1 US 20030204067A1 US 43681303 A US43681303 A US 43681303A US 2003204067 A1 US2003204067 A1 US 2003204067A1
- Authority
- US
- United States
- Prior art keywords
- separation medium
- groups
- group
- composition
- nucleic acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920000867 polyelectrolyte Polymers 0.000 title claims abstract description 20
- 150000007523 nucleic acids Chemical class 0.000 title abstract description 52
- 102000039446 nucleic acids Human genes 0.000 title abstract description 51
- 108020004707 nucleic acids Proteins 0.000 title abstract description 51
- 238000000034 method Methods 0.000 title abstract description 27
- 238000000746 purification Methods 0.000 title abstract description 21
- 239000000463 material Substances 0.000 title abstract description 10
- 238000000926 separation method Methods 0.000 claims abstract description 74
- 230000001419 dependent effect Effects 0.000 claims abstract description 15
- 229920000936 Agarose Polymers 0.000 claims description 32
- 239000011148 porous material Substances 0.000 claims description 17
- 229920000642 polymer Polymers 0.000 claims description 16
- 150000004676 glycans Chemical class 0.000 claims description 13
- 229920001282 polysaccharide Polymers 0.000 claims description 13
- 239000005017 polysaccharide Substances 0.000 claims description 13
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 10
- 230000002378 acidificating effect Effects 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 229920000858 Cyclodextrin Polymers 0.000 claims description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 6
- 150000007530 organic bases Chemical class 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- 229920002307 Dextran Polymers 0.000 claims description 4
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 150000007524 organic acids Chemical group 0.000 claims description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 2
- 230000001747 exhibiting effect Effects 0.000 claims 2
- 238000011084 recovery Methods 0.000 claims 2
- 239000000758 substrate Substances 0.000 claims 2
- UMHSKYSHOIGDPE-UHFFFAOYSA-N pyridine;quinoline Chemical compound C1=CC=NC=C1.N1=CC=CC2=CC=CC=C21 UMHSKYSHOIGDPE-UHFFFAOYSA-N 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 21
- 230000007935 neutral effect Effects 0.000 abstract description 13
- 108091005461 Nucleic proteins Proteins 0.000 abstract 2
- 239000000243 solution Substances 0.000 description 42
- 108020004414 DNA Proteins 0.000 description 31
- 102000053602 DNA Human genes 0.000 description 31
- 239000011324 bead Substances 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 239000000499 gel Substances 0.000 description 18
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 14
- 239000000872 buffer Substances 0.000 description 14
- 239000004202 carbamide Substances 0.000 description 14
- 238000010828 elution Methods 0.000 description 11
- 102000040430 polynucleotide Human genes 0.000 description 11
- 108091033319 polynucleotide Proteins 0.000 description 11
- 239000002157 polynucleotide Substances 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 239000002585 base Substances 0.000 description 10
- 230000005291 magnetic effect Effects 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 8
- 230000008569 process Effects 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000011534 wash buffer Substances 0.000 description 5
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- -1 dimethylaminoethyl Chemical group 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 230000005298 paramagnetic effect Effects 0.000 description 4
- WZIYCIBURCPKAR-UHFFFAOYSA-N 4-(chloromethyl)pyridine Chemical compound ClCC1=CC=NC=C1 WZIYCIBURCPKAR-UHFFFAOYSA-N 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000006249 magnetic particle Substances 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 229920002477 rna polymer Polymers 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- HPYNZHMRTTWQTB-UHFFFAOYSA-N 2,3-dimethylpyridine Chemical compound CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 2
- JYYNAJVZFGKDEQ-UHFFFAOYSA-N 2,4-Dimethylpyridine Chemical compound CC1=CC=NC(C)=C1 JYYNAJVZFGKDEQ-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 2
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 2
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- HWWYDZCSSYKIAD-UHFFFAOYSA-N 3,5-dimethylpyridine Chemical compound CC1=CN=CC(C)=C1 HWWYDZCSSYKIAD-UHFFFAOYSA-N 0.000 description 2
- ITQTTZVARXURQS-UHFFFAOYSA-N 3-methylpyridine Chemical compound CC1=CC=CN=C1 ITQTTZVARXURQS-UHFFFAOYSA-N 0.000 description 2
- MUDSDYNRBDKLGK-UHFFFAOYSA-N 4-methylquinoline Chemical compound C1=CC=C2C(C)=CC=NC2=C1 MUDSDYNRBDKLGK-UHFFFAOYSA-N 0.000 description 2
- 102100030497 Cytochrome c Human genes 0.000 description 2
- 108010075031 Cytochromes c Proteins 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000007863 gel particle Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000012145 high-salt buffer Substances 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical compound C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- XFNJYAKDBJUJAJ-UHFFFAOYSA-N 1,2-dibromopropane Chemical compound CC(Br)CBr XFNJYAKDBJUJAJ-UHFFFAOYSA-N 0.000 description 1
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- PCFUWBOSXMKGIP-UHFFFAOYSA-N 2-benzylpyridine Chemical compound C=1C=CC=NC=1CC1=CC=CC=C1 PCFUWBOSXMKGIP-UHFFFAOYSA-N 0.000 description 1
- QHCCOYAKYCWDOJ-UHFFFAOYSA-N 2-ethyl-1h-benzimidazole Chemical compound C1=CC=C2NC(CC)=NC2=C1 QHCCOYAKYCWDOJ-UHFFFAOYSA-N 0.000 description 1
- NRGGMCIBEHEAIL-UHFFFAOYSA-N 2-ethylpyridine Chemical compound CCC1=CC=CC=N1 NRGGMCIBEHEAIL-UHFFFAOYSA-N 0.000 description 1
- LDZYRENCLPUXAX-UHFFFAOYSA-N 2-methyl-1h-benzimidazole Chemical compound C1=CC=C2NC(C)=NC2=C1 LDZYRENCLPUXAX-UHFFFAOYSA-N 0.000 description 1
- DWYHDSLIWMUSOO-UHFFFAOYSA-N 2-phenyl-1h-benzimidazole Chemical compound C1=CC=CC=C1C1=NC2=CC=CC=C2N1 DWYHDSLIWMUSOO-UHFFFAOYSA-N 0.000 description 1
- DPXZCTJBRDTGFZ-UHFFFAOYSA-N 4-(2-chloroethyl)pyridine Chemical compound ClCCC1=CC=NC=C1 DPXZCTJBRDTGFZ-UHFFFAOYSA-N 0.000 description 1
- ZAWHIODTAHOCQN-UHFFFAOYSA-N 4-ethylpyridine;4-methylpyridine Chemical compound CC1=CC=NC=C1.CCC1=CC=NC=C1 ZAWHIODTAHOCQN-UHFFFAOYSA-N 0.000 description 1
- HFDLDPJYCIEXJP-UHFFFAOYSA-N 6-methoxyquinoline Chemical compound N1=CC=CC2=CC(OC)=CC=C21 HFDLDPJYCIEXJP-UHFFFAOYSA-N 0.000 description 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methyl-N-phenylamine Natural products CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920010741 Ultra High Molecular Weight Polyethylene (UHMWPE) Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- MIROPXUFDXCYLG-UHFFFAOYSA-N pyridine-2,5-diamine Chemical compound NC1=CC=C(N)N=C1 MIROPXUFDXCYLG-UHFFFAOYSA-N 0.000 description 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/262—Synthetic macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. obtained by polycondensation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/265—Synthetic macromolecular compounds modified or post-treated polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28009—Magnetic properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28095—Shape or type of pores, voids, channels, ducts
- B01J20/28097—Shape or type of pores, voids, channels, ducts being coated, filled or plugged with specific compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/16—Organic material
- B01J39/18—Macromolecular compounds
- B01J39/19—Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
- B01J41/08—Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
- B01J41/12—Macromolecular compounds
- B01J41/13—Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0036—Galactans; Derivatives thereof
- C08B37/0039—Agar; Agarose, i.e. D-galactose, 3,6-anhydro-D-galactose, methylated, sulfated, e.g. from the red algae Gelidium and Gracilaria; Agaropectin; Derivatives thereof, e.g. Sepharose, i.e. crosslinked agarose
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/12—Agar or agar-agar, i.e. mixture of agarose and agaropectin; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
Definitions
- This invention relates to separation and purification of polyelectrolytes.
- the present invention relates to the purification of biochemical materials such as proteins and more particularly nucleic acids.
- nucleic acid and polynucleotide are used interchangeably, and are used here to signify either a deoxyribonucleic acid (DNA) or a ribonucleic acid (RNA). Unless otherwise specified, the terms polynucleotide and oligonucleotide are used interchangeably.
- BACKUS et al (U.S. Pat. Nos. 5,582,988 and 5,622,822, and CA 2157968) describes a method for isolation of nucleic acids from a lysate by contacting with polymers containing basic groups, such as polyethyleneimine.
- polymers containing basic groups such as polyethyleneimine.
- an acidic medium was required for binding, and a strong alkali and heat were found to be the agents most successful in releasing, or eluting, the nucleic acids from the polymer.
- COLPAN et al (DE patent number 4139664) describe a method for isolating nucleic acid from cells—by lysis of the cells, then elution of nucleic acid fixed to separation medium surface. However, the method recovers the nucleic acids by eluting with a buffer of high ionic strength.
- HENCO et al (DE 3639949) describes a method for the Separation of long-chain nucleic acids—using a porous separation medium to fix the nucleic acids.
- the invention uses selective salt elution to first wash off the short chain nucleic acids whereas the long-chain nucleic acids are subsequently removed from the anion exchanger using a washing solution of high ionic strength.
- SELIGSON and SHRAWDER describe the classical method of isolation of nucleic acids by chromatography on anion exchanger using salt gradients. After the nucleic acids become bound to the ion exchange material and washed, the bound nucleic acids are eluted by passing through the column a salt solution of high molarity.
- GANNON (EP 366438) describes the separation of nucleic acid from protein by contacting with cation exchanger at pH below isoelectric point of a protein, i.e., it binds the proteins not the DNA.
- BRUCE et al (Patent Number WO 9411103; GB 9223334) describes magnetizable polymer-based particles derived with ligand having direct binding affinity for nucleic acids etc., for the separation of nucleic acids.
- the polymer is agarose.
- the ligand is one capable of assuming a positive charge at pH 7 or below, and is capable of reversibly binding directly to a negatively charged group or moiety in the target molecules.
- the selected ligands are amines, such as dimethylaminoethyl, and triethanolamine; all have a pKa higher than in our invention.
- ADRIAANSE et al (EP 389063 A) describe a method that is widely adapted as diagnostics kits in the art, namely the isolation of nucleic acid using chaotropic agents for nucleic acid binding to solid phase.
- the present invention avoids the use of highly concentrated chaotropes during purification.
- NELSON et al (EP 281390) offered a method for the separation of small nucleotides from larger ones by binding to polycationic support—which does not retain smaller sequences for hybridization assays.
- the bound nucleic acids were apparently eluted, if needed, by 50% formamide, or other salts.
- JP 06335380 A describes a carrier for bonding nucleic acid, which has hybrid-forming base sequence fixed over surface of insoluble solid fine particles.
- the base of binding is the interaction between complimentary sequences of polynucleotides.
- U.S. Pat. No. 4,672,040 also describes a silanized magnetic particles, for use in nucleic acid hybridization, where the principle of binding is the interaction between the hybrid-forming base sequence fixed over surface of insoluble solid fine particles.
- MACFARLANE uses quaternary amine surfactants for isolating nucleic acids from a biological sample by forming complexes which can be dissociated.
- HILL (WO 8605815) also describes the use of magnetized nucleic acid sequence comprising single or double-stranded nucleic acid linked to magnetic or magnetizable substance.
- HORNES and KORSNES (U.S. Pat. No. 5,512,439) also describe the detection and quantitative determination of target RNA or DNA—by contacting sample with magnetic particles carrying 5′-attached DNA probe.
- REEVE U.S. Pat. No. 5,523,231 describes a method of making a product solution containing a nucleic acid by treating a starting solution containing the nucleic acid by the use of suspended magnetically attractable beads which do not specifically bind the nucleic acid, by precipitating the nucleic acid out of the starting solution in the presence of the suspended magnetic beads whereby a nucleic acid precipitate becomes aggregated with and entraps the beads, followed by separating the precipitate and the entrapped beads and adding a liquid to the precipitate and the entrapped beads to re-dissolve the nucleic acid and re-suspend the beads.
- the present invention is directed to polymeric separation media and to methods useful for the purification of polyelectrolytes, particularly polynucleotides.
- the present invention provides mild conditions that avoid the unfavorable, and sometimes harsh conditions otherwise required to bind and elute biomolecules in related art.
- prior nucleic acid isolation or purification methods include steps such as heating, and reagents such as strong alkalis, or highly concentrated salts and chaotropes. In addition to being automation and operator unfriendly, these steps/reagents require additional efforts to implement, neutralize, or remove.
- the polymeric separation media possess multiple pendant groups, i.e., functional groups, whose protonation state is pH-dependent. Consequently, the amount of charge created on the separation medium can be controlled by adjustment to the pH of the buffer solution where the polymeric separation medium is suspended.
- Bound proteins can be washed off the separation medium by the choice of the pH of the wash buffer. Elution may also be carried in multiple steps, each with an increasing pH, where proteins would elute first, while DNA elutes last.
- a negatively charged polyelectrolyte binds to the separation medium at pH 7, as discussed above, and can be eluted in steps with change of the pH to 8 to 10, thus washing off the proteins at pH 8, while eluting DNA at the higher pH.
- DNA and protein molecules can be selectively separated form a mixture thereof.
- the binding step of the positively charged polymeric separation medium occur at a neutral pH where the separation medium is not maximally charged. If the separation medium carries a high positive charge density, then the binding to the highly negatively charged DNA would be too strong to be separated without recourse to harsh conditions, as observed in the prior art listed above.
- a purification method using such a separation medium is capable of discriminating between the binding ability of the pH-dependent groups to the different solutes present in a mixture.
- the separation medium can also selectively elute polyelectrolytes.
- an aspect of the present invention is that the pendant groups carry a certain amount of positive charges at neutral pH. It is clear from the discussion above that pendant groups with pKa of about 6 to 7 can bind polynucleotides, and quite strongly at neutral pH. As such, the binding step can thus be accomplished at neutral pH.
- the polymeric separation medium is water-insoluble.
- the polymeric separation medium encapsulates a magnetic core, so that it can be separated by the application of a magnetic field.
- the polymeric separation medium contains pendant groups that exhibit pKa values of less that about 7, and the medium (buffer) containing the polymeric separation medium is buffered so that the pH of the buffer has a neutral value, thus causing the pendant groups of the polymeric separation medium to be not completely protonated (positively charged) at pH of at least 7.
- Preferred pendant basic groups are derived from a base which is a member of the group consisting of pyridine, quinoline, imidazole, and pyrimidine.
- Preferred pendant acidic groups are members of the group consisting of a carboxylic group and a phenolic group.
- FIGS. 1 (A) through 1 (D) illustrate the formation of a polymeric medium over a period of time and embodying this invention.
- the medium is made by slowly adding water, 11 , on top of a 2.5% (W/V) agarose solution in 8M urea, 12 .
- a thin layer of gel, 13 which forms at the interface of the agarose and water layers, grows in thickness until all the agarose gels as time progresses from FIG. 1(A) to FIG. 1(D), and as described in Example 1;
- FIG. 2 is a schematic illustration of a cylindrical configuration of a porous support, 21 , embodied within an inert casing, 22 , after the pores of the support have been impregnated with the gel material, 23 , which can be modified to carry pH-dependent groups as in FIG. 4(A).
- the path of the liquid flow through an inlet port 24 , the gel material, 23 , and the exit port, 25 is indicated by arrows;
- FIG. 3 is a schematic illustration of a flat membrane configuration of a porous support, 31 , embodied within a casing, 32 , after the pores of the support have been impregnated with the polymeric medium, 33 .
- This medium can be modified to carry pH-dependent groups as in FIG. 4(A), and showing the path of the liquid through an inlet port 34 , the gel material, 33 , and the exit port, 35 ;
- FIG. 4(A) is a schematic of a polymeric separation medium, 41 , provided with pendant groups, RH that are pH dependent.
- the polymeric separation medium may be one of polysaccharide, silica, or other polymers that can be functionalized to attach the groups. These are acid-base groups, and depending on the ambient pH value, the groups can be protonated, as shown (RH), or deprotonated (R).
- the groups can be a basic nitrogen, which can be protonated (NH + ) for polynucleotide purification, or the groups can be a deprotonated carboxyl (—COO ⁇ ) or a deprotonated phenolic (—C 6 H 4 —O—) for the purification of positively charged proteins.
- FIG. 4(B) shows a schematic where the polymeric separation medium, 41 , surrounds a magnetic core, 42 , such as paramagnetic iron oxide.
- the polymeric separation media possess functional groups that are pH dependent, such as organic acids and organic bases.
- the pKa of the pH-dependent groups is chosen to be near or slightly below the neutral pH range, e.g., 5 to 7.
- the pKa is that of the conjugated acid (base+proton).
- base+proton usually containing nitrogen atoms
- the separation medium acquires positive electrical charges, and bind negatively charged polyelectrolytes, such as nucleic acids and negatively charged proteins.
- the unbound solutes can be separated from the separation medium, and the separation medium can be washed with a low pH buffer. Raising the pH to a value above the pKa of the organic base will force the separation medium to loose its positive charges (protons), and thus release the bound nucleic acids in a pure form.
- the separation medium is made to acquire negative electrical charges, and thus binds to positively charged polyelectrolytes, such as positively charged proteins.
- the unbound solutes can be separated from the separation medium, and the separation medium can be washed with a high pH buffer. Lowering the pH to a value below the pKa of the acidic groups will force the groups to loose their negative charges (by acquiring protons), and thus release the bound polyelectrolytes.
- the pKa of the basic groups is chosen to be near or slightly below neutral pH to avoid the harsh conditions that will be required otherwise to release polyelectrolytes, especially biomolecules.
- the pKa is around 5 to 7, then polyelectrolytes can bind at pH 7, as discussed above, and can be eluted by a change of the pH to 8 to 10 (weakly basic).
- the basic group in a particularly preferred embodiment is p(2-chloroethyl) pyridine (4-picolyl chloride), and similar pyridine, quinoline, imidazole, and pyrimidine derivatives, with near neutral pKa, such as 2-ethyl benzimidazole (6.18), 2-methyl benzimidazole (6.19), 2-phenyl benzimidazole (5.23), isoquinoline (5.42), papaverine (6.4), pyrimidine (6.35), phenanthridine (5.58), p-phenitidine (5.20), 2-picoline (5.97), 3-picoline (5.68), 4-picoline (6.02), pilocarpine (6.87), 2-amino pyridine (6.82), 2-benzyl pyridine (5.13), 2,5-diamino pyridine (6.48), 2,3-dimethyl pyridine (6.57), 2,4-dimethyl pyridine (6.99), 3,5-dimethyl
- a positively charged polyelectrolyte binds to the separation medium at pH 7, and is eluted by a buffer solution of pH value of about 5 (weakly acidic).
- the present invention also describes polymeric separation media suitable for implementing purification, by chemically attaching the above mentioned pH-dependent functional groups to such polymeric separation media, as in FIG. 4(A).
- the polymeric separation medium is one of polysaccharide, silica, or polyacrylamide polymers.
- the polysaccharide is preferably an agarose, a dextran, or a cyclodextrin, and derivatives thereof.
- Typical cyclodextrins are the ⁇ , ⁇ - and ⁇ -cyclodextrins.
- the sample containing the nucleic acids to be purified is equilibrated with the polymeric separation medium in particulate form (gel particles) carrying pH-dependent groups at pH near the pKa of the groups, where the nucleic acids can preferentially bind to the gel particles.
- the particles are allowed to separate from the sample solution by gravitational settling or centrifugation, and the unbound solution is aspirated.
- the particles are washed with a buffer also having a pH near the pKa of the basic groups, and the wash buffer is again aspirated after separation from the particles.
- the bound nucleic acids may be eluted by a buffer having pH approximately 3 units higher than the pKa of the basic groups, thus releasing the nucleic acids in pure form.
- the above polymeric separation medium surrounds a magnetic core, such as paramagnetic iron oxide particles, as described schematically in FIG. 4(B).
- magnetic particles may be coated by polymers, using techniques known in the art, to form magnetized separation media in particulate form.
- the polymer may be subsequently functionalized with pH-dependent groups as discussed herein.
- the particles are separated from the solution.
- the particles are washed with a buffer, also having a pH near the pKa of the basic groups and the particles are again separated using a magnet, and the wash buffer is aspirated.
- the bound nucleic acids may be eluted from the particles by a buffer having pH approximately 3 units higher than the pKa of the basic groups, thus releasing the nucleic acids in pure form.
- the separation medium is a gel that pervades the pores of a porous support to form a continuous phase.
- the porous support is fabricated into a device for the separation using convective flow.
- the device is formed by imbibing a dissolved, gellable polymer into the pores of the porous support.
- the polymer is dissolved by the use of chaotropes. Chaotropes are small solutes that influence the solution behavior of a solvent and its dissolving power. Chaotropes can give the solution the capacity to dissolve polymers that are normally sparingly soluble in the pure solvent.
- the polymer is a polysaccharide and the chaotrope is urea, guanidinium salts, or KI.
- agarose was dissolved in water solution containing 8M urea. This process yields solutions of agarose, which do not gel at room temperature. If water is carefully added to such a solution, a thin gel layer forms at the interface between the agarose solution and the water. The gel layer prevents the migration of the polysaccharide, but still allows further migration of the much smaller urea molecules. As the urea molecules leave the agarose solution into the mainly water medium, the agarose further gels until all the agarose solution turns into gel. The resulting gel can be further chemically modified to attach the pH-dependent groups described above to be used as a separation medium. This process is schematically depicted in FIG. 1(A) through FIG. 1(D), and further explained in Examples 1 through 3.
- the porous support can take several forms, preferably a cylindrical shape or a flat shape, as shown in FIGS. 2 and 3, respectively.
- the polysaccharide solution just described is pushed or drawn by vacuum to impregnate the pores of a porous support, and the excess solution is drained off.
- the chaotrope (urea) is allowed to migrate from the polysaccharide solution by diffusion through the pores of the support when soaking in water.
- the agarose gels in the pores of the support.
- the agarose thus becomes entrapped in the pores of the support.
- This gelling process appears to be unique and gives a stable and reproducible pore-size distribution that is useful for the purpose of this invention.
- the resulting gel in the above process can be further locked inside the pores by cross-linking of the agarose with a cross-linking agent such as epichlorohydrin and 1,2-dibromo propane.
- the porous support material may be made of a number of polymeric, glass, metallic and ceramic materials.
- the porous support may be fabricated from ultra high density polyethylene, or polypropylene composition, that is formed into the shape and configuration as shown in FIGS. 2 and 3, which can be obtained from Porex Company, located at Fairburn, Ga.
- the sample containing the nucleic acids to be purified is passed through polymeric separation medium containing basic groups, formed in the pores of the porous support.
- Wash buffer is then flown to wash off unbound solutes. Wash buffers may have the same pH as the binding buffer ( ⁇ 7).
- the bound nucleic acids may be eluted by a buffer having pH approximately 3 units higher than the pKa of the basic groups, thus releasing the nucleic acids in substantially pure form.
- agarose (Sigma Chemical Co., St. Louis, Mo., product number A9918) were dissolved in one liter of 8M urea solution by heating the solution with stirring until the solution became clear, forming layer 12 , in FIG. 1.
- the medium is made by slowly adding water, 11 , on top of a 2.5% (W/V) agarose solution in 8M urea, 12 .
- a thin layer of gel, 13 which forms at the interface of the agarose and water layers, grows in thickness until all the agarose gels as time progresses from FIG. 1(A) to FIG. 1(D), and as described in Example 1. This solution remained ungelled after cooling to room temperature for a period of over 150 days.
- a gelled layer, 13 forms at the interface. This is indicated by the appearance of a white color.
- This layer plays an important role in preventing further mixing of the water with the agarose in the chaotropic solution. Water and urea molecules can cross this layer, but the agarose molecules, being considerably larger, remain in the bottom layer. At longer times, more urea molecules diffused to the top layer, until the whole bottom part became gelled, as shown in FIGS. 1 (A) to 1 (D). This solution behavior of agarose was repeated with quantities of agarose concentrations varying from 0.5 to 4% (in 8M urea solution).
- UHMWPE ultra high molecular weight polyethylene
- 9.5 mm O.D., 4.8 mm I.D., and 35 mm long was used, with one end sealed and the other open.
- This cylinder had nominal pore size of 20 microns and void volume (empty space in the walls of the cylinder) of approximately 50%.
- the inner bore of the cylinder was blocked by a rod of the same diameter as the ID of the cylinder to prevent the agarose solution from filling the bore.
- Agarose (2.5% w/v) was solubilized in 8M Urea as in Example 1.
- the agarose solution was vacuum drawn into the pores of the cylinder using a vacuum pump.
- the cylinder was soaked in water overnight.
- this cylinder is numbered 21 .
- the rod was removed from the cylinder.
- a luer fitting attachment, 24 was sealed to the open end of the cylinder, and was used to attach the device to syringes or peristaltic pumps for the purpose of processing fluids.
- the device was placed in a casing, 22 .
- the liquid permeability decreased from approximately 1800 for the gel-free device to about 8 after this step, indicating filling of the pores with the gel.
- the agarose-filled cylinder in Example 2 was equilibrated in 1M NaOH for 4 hours. The NaOH was drained out and the agarose was cross-linked using 3% epichlorohydrin in 95% (V/V) ethanol/water mixture for 16 hours at room temperature. The resulting cross-linked gel can be used a filtration device. The liquid permeability of the device after cross-linking increased slightly to about 10.
- the agarose was cross-linked and re-equilibrated in 10% NaOH in a cylinder as in Examples 2-3. The cylinder was then allowed to react with 10% (W/V) chloroacetic acid in 95% (W/V) reagent alcohol-water for 16 hours. This cylinder produced a device with carboxyl group modified agarose as a weak cation exchanger.
- Sephadex G-50 beads polysaccharide consisting of dextran and cross-linked agarose, Sigma Chemical Co., St, St. Louis, Mo.
- the liquid was aspirated and the beads were washed repeatedly with water until the color disappeared.
- the beads were functionalized to produce a DNA purifier, since p-ethyl pyridine (gamma picoline) has a pKa of about 6, it can bind DNA at neutral pH's and release DNA at moderately high pH (9).
- the polymeric separation medium may be one of polysaccharide, silica, or other polymers that can be functionalized to attach the groups. These are acid-base groups, and depending on the ambient pH value, the groups can be protonated, as shown (RH), or deprotonated (R).
- the groups can be a basic nitrogen, which can be protonated (—NH + ) for polynucleotide purification, or the groups can be a deprotonated carboxyl (—COO—) or a deprotonated phenolic (—C 6 H 4 —O-) for the purification of positively charged proteins.
- FIG. 4(B) shows a schematic where the polymeric separation medium, 41 , surrounds a magnetic core, 42 , such as paramagnetic iron oxide.
- PBKSRV plasmid plasmid, from Strategene, ⁇ 8 kb in length
- Paramagnetic iron oxide beads coated with silica were treated to produce a DNA purifier in a method similar to that in Example 7, by attaching 4-picoline to the silica separation medium.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Materials Engineering (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
- This application is a division of U.S. patent application Ser. No. 09/840,570 filed on Apr. 23, 2001, now U.S. Pat. No. 6,562,573, which is a continuation-in-part of U.S. patent application Ser. No. 09/238,343 filed on Jan. 27, 1999, now abandoned, which, in turn, is a continuation-in-part of U.S. patent application Ser. No. 07/772,346 filed on Oct. 7, 1991, now abandoned.
- This invention relates to separation and purification of polyelectrolytes. In particular, the present invention relates to the purification of biochemical materials such as proteins and more particularly nucleic acids.
- Purification of molecular species constitutes a crucial part to their production and utility. This is particularly important in the biotechnology and diagnostics fields. The present invention describes polymeric separation media and methods useful for the purification of molecular species that are polyelectrolytes, such as proteins and nucleic acids. The terms nucleic acid and polynucleotide are used interchangeably, and are used here to signify either a deoxyribonucleic acid (DNA) or a ribonucleic acid (RNA). Unless otherwise specified, the terms polynucleotide and oligonucleotide are used interchangeably.
- There is a large body of publications dealing with synthesis, functionalization, and use of ion-exchangers for chromatography and biomolecule purification. (The following patents are herein incorporated by reference in their entirety.) BACKUS et al (U.S. Pat. Nos. 5,582,988 and 5,622,822, and CA 2157968) describes a method for isolation of nucleic acids from a lysate by contacting with polymers containing basic groups, such as polyethyleneimine. However, an acidic medium was required for binding, and a strong alkali and heat were found to be the agents most successful in releasing, or eluting, the nucleic acids from the polymer.
- COLPAN et al (DE patent number 4139664) describe a method for isolating nucleic acid from cells—by lysis of the cells, then elution of nucleic acid fixed to separation medium surface. However, the method recovers the nucleic acids by eluting with a buffer of high ionic strength.
- HENCO et al (DE 3639949) describes a method for the Separation of long-chain nucleic acids—using a porous separation medium to fix the nucleic acids. The invention uses selective salt elution to first wash off the short chain nucleic acids whereas the long-chain nucleic acids are subsequently removed from the anion exchanger using a washing solution of high ionic strength.
- SELIGSON and SHRAWDER (U.S. Pat. No. 4,935,342) describe the classical method of isolation of nucleic acids by chromatography on anion exchanger using salt gradients. After the nucleic acids become bound to the ion exchange material and washed, the bound nucleic acids are eluted by passing through the column a salt solution of high molarity.
- GANNON (EP 366438) describes the separation of nucleic acid from protein by contacting with cation exchanger at pH below isoelectric point of a protein, i.e., it binds the proteins not the DNA.
- Similar principles are offered in U.S. Pat. No. 3,433,782, where selective elution steps effected with varied molarities of LiCLO4 or NaClO4.
- Similar principles are offered in U.S. Pat. No. 434,324, where purification of deoxyribonucleic acid is accomplished by using anion exchange material, washing with weak ionic salt solution and elution with strong ionic salt solution.
- Similar principles are offered by Bourque and Cohen (WO 9514087), where detection of charged oligonucleotides is accomplished by adsorbing on an ion exchange resin, eluting with a high salt buffer and detection. The oligonucleotides bind to the anion exchange resin at 40-65° C., while the desorbing from the resin with a high salt buffer is performed at40-65° C.
- BRUCE et al (Patent Number WO 9411103; GB 9223334) describes magnetizable polymer-based particles derived with ligand having direct binding affinity for nucleic acids etc., for the separation of nucleic acids. The polymer is agarose. The ligand is one capable of assuming a positive charge at pH 7 or below, and is capable of reversibly binding directly to a negatively charged group or moiety in the target molecules. The selected ligands are amines, such as dimethylaminoethyl, and triethanolamine; all have a pKa higher than in our invention.
- ADRIAANSE et al (EP 389063 A) describe a method that is widely adapted as diagnostics kits in the art, namely the isolation of nucleic acid using chaotropic agents for nucleic acid binding to solid phase. The use of high concentration of chaotropes, e.g., guanidinium thiocyanate, forces the DNA to precipitate and interact with many surfaces. The present invention avoids the use of highly concentrated chaotropes during purification.
- NELSON et al (EP 281390) offered a method for the separation of small nucleotides from larger ones by binding to polycationic support—which does not retain smaller sequences for hybridization assays. The bound nucleic acids were apparently eluted, if needed, by 50% formamide, or other salts.
- JP 06335380 A describes a carrier for bonding nucleic acid, which has hybrid-forming base sequence fixed over surface of insoluble solid fine particles. The base of binding is the interaction between complimentary sequences of polynucleotides.
- U.S. Pat. No. 4,672,040 also describes a silanized magnetic particles, for use in nucleic acid hybridization, where the principle of binding is the interaction between the hybrid-forming base sequence fixed over surface of insoluble solid fine particles.
- MACFARLANE (U.S. Pat. No. 5,300,635), uses quaternary amine surfactants for isolating nucleic acids from a biological sample by forming complexes which can be dissociated.
- HILL (WO 8605815) also describes the use of magnetized nucleic acid sequence comprising single or double-stranded nucleic acid linked to magnetic or magnetizable substance.
- HORNES and KORSNES (U.S. Pat. No. 5,512,439) also describe the detection and quantitative determination of target RNA or DNA—by contacting sample with magnetic particles carrying 5′-attached DNA probe.
- REEVE (U.S. Pat. No. 5,523,231) describes a method of making a product solution containing a nucleic acid by treating a starting solution containing the nucleic acid by the use of suspended magnetically attractable beads which do not specifically bind the nucleic acid, by precipitating the nucleic acid out of the starting solution in the presence of the suspended magnetic beads whereby a nucleic acid precipitate becomes aggregated with and entraps the beads, followed by separating the precipitate and the entrapped beads and adding a liquid to the precipitate and the entrapped beads to re-dissolve the nucleic acid and re-suspend the beads.
- The present invention is directed to polymeric separation media and to methods useful for the purification of polyelectrolytes, particularly polynucleotides.
- In contrast to the prior art methods, the present invention provides mild conditions that avoid the unfavorable, and sometimes harsh conditions otherwise required to bind and elute biomolecules in related art. As mentioned above, prior nucleic acid isolation or purification methods include steps such as heating, and reagents such as strong alkalis, or highly concentrated salts and chaotropes. In addition to being automation and operator unfriendly, these steps/reagents require additional efforts to implement, neutralize, or remove.
- The polymeric separation media possess multiple pendant groups, i.e., functional groups, whose protonation state is pH-dependent. Consequently, the amount of charge created on the separation medium can be controlled by adjustment to the pH of the buffer solution where the polymeric separation medium is suspended. As an example, if the pendant groups are basic (B) and possess a pKa of 7, then, at neutral pH (i.e., pH=7), 50% of the groups will acquire positive charges (BH+). Since the pH scale is logarithmic, then, at pH=8, the percent of the positively charged groups will drop to 10%, and to 1% at pH=9. Similarly, if the basic groups possess a pKa of 6, then at pH=9, only 0.1% of the groups will be positively charged, and so forth.
- It is an aspect of this invention that at neutral pH, basic groups with pKa as stated above can bind, preferentially strongly, to polyelectrolytes with high negative charge density, such as polynucleotides. At low amount of the positive charges, the separation medium will bind preferably to polyelectrolytes with the most negative charges, such as DNA. Other polyelectrolytes such as proteins, even though they may possess negative charges, will not bind as strongly. The difference in binding strength is attributed to the nature of the charge distribution on polynucleotides and proteins, with polynucleotides possessing multiple, repeated negative charges. As the polymeric separation medium possesses multiplicity of positive charges, even when not totally protonated, multiple electrical interaction (attraction) can occur with the multiple negative charges on the polynucleotides. Bound proteins can be washed off the separation medium by the choice of the pH of the wash buffer. Elution may also be carried in multiple steps, each with an increasing pH, where proteins would elute first, while DNA elutes last. In a preferred embodiment, a negatively charged polyelectrolyte binds to the separation medium at pH 7, as discussed above, and can be eluted in steps with change of the pH to 8 to 10, thus washing off the proteins at pH 8, while eluting DNA at the higher pH. In the above scheme, DNA and protein molecules can be selectively separated form a mixture thereof.
- It is an important aspect of this invention, and one of its most preferred embodiments to purify nucleic acids, that the binding step of the positively charged polymeric separation medium occur at a neutral pH where the separation medium is not maximally charged. If the separation medium carries a high positive charge density, then the binding to the highly negatively charged DNA would be too strong to be separated without recourse to harsh conditions, as observed in the prior art listed above.
- A purification method using such a separation medium is capable of discriminating between the binding ability of the pH-dependent groups to the different solutes present in a mixture. In addition to selectively binding polyelectrolytes, the separation medium can also selectively elute polyelectrolytes.
- Toward operating under mild conditions, an aspect of the present invention is that the pendant groups carry a certain amount of positive charges at neutral pH. It is clear from the discussion above that pendant groups with pKa of about 6 to 7 can bind polynucleotides, and quite strongly at neutral pH. As such, the binding step can thus be accomplished at neutral pH.
- In a preferred embodiment, the polymeric separation medium is water-insoluble. In another preferred embodiment, the polymeric separation medium encapsulates a magnetic core, so that it can be separated by the application of a magnetic field.
- In another preferred embodiment the polymeric separation medium contains pendant groups that exhibit pKa values of less that about 7, and the medium (buffer) containing the polymeric separation medium is buffered so that the pH of the buffer has a neutral value, thus causing the pendant groups of the polymeric separation medium to be not completely protonated (positively charged) at pH of at least 7.
- Preferred pendant basic groups are derived from a base which is a member of the group consisting of pyridine, quinoline, imidazole, and pyrimidine.
- Preferred pendant acidic groups are members of the group consisting of a carboxylic group and a phenolic group.
- FIGS.1(A) through 1(D) illustrate the formation of a polymeric medium over a period of time and embodying this invention. The medium is made by slowly adding water, 11, on top of a 2.5% (W/V) agarose solution in 8M urea, 12. A thin layer of gel, 13, which forms at the interface of the agarose and water layers, grows in thickness until all the agarose gels as time progresses from FIG. 1(A) to FIG. 1(D), and as described in Example 1;
- FIG. 2 is a schematic illustration of a cylindrical configuration of a porous support,21, embodied within an inert casing, 22, after the pores of the support have been impregnated with the gel material, 23, which can be modified to carry pH-dependent groups as in FIG. 4(A). The path of the liquid flow through an
inlet port 24, the gel material, 23, and the exit port, 25 is indicated by arrows; - FIG. 3 is a schematic illustration of a flat membrane configuration of a porous support,31, embodied within a casing, 32, after the pores of the support have been impregnated with the polymeric medium, 33. This medium can be modified to carry pH-dependent groups as in FIG. 4(A), and showing the path of the liquid through an
inlet port 34, the gel material, 33, and the exit port, 35; - FIG. 4(A) is a schematic of a polymeric separation medium,41, provided with pendant groups, RH that are pH dependent. The polymeric separation medium may be one of polysaccharide, silica, or other polymers that can be functionalized to attach the groups. These are acid-base groups, and depending on the ambient pH value, the groups can be protonated, as shown (RH), or deprotonated (R). The groups can be a basic nitrogen, which can be protonated (NH+) for polynucleotide purification, or the groups can be a deprotonated carboxyl (—COO−) or a deprotonated phenolic (—C6H4—O—) for the purification of positively charged proteins. FIG. 4(B) shows a schematic where the polymeric separation medium, 41, surrounds a magnetic core, 42, such as paramagnetic iron oxide.
- The polymeric separation media possess functional groups that are pH dependent, such as organic acids and organic bases. The pKa of the pH-dependent groups is chosen to be near or slightly below the neutral pH range, e.g., 5 to 7. For organic bases, usually containing nitrogen atoms, the pKa is that of the conjugated acid (base+proton). In the case of organic bases, if the pH is lowered to at or below the pKa, the bases acquire protons to form the conjugate acids. The separation medium thus acquires positive electrical charges, and bind negatively charged polyelectrolytes, such as nucleic acids and negatively charged proteins. The unbound solutes can be separated from the separation medium, and the separation medium can be washed with a low pH buffer. Raising the pH to a value above the pKa of the organic base will force the separation medium to loose its positive charges (protons), and thus release the bound nucleic acids in a pure form.
- On the other hand, if the functional group is an organic acid, and the pH is raised to at, or above, its pKa, the separation medium is made to acquire negative electrical charges, and thus binds to positively charged polyelectrolytes, such as positively charged proteins. The unbound solutes can be separated from the separation medium, and the separation medium can be washed with a high pH buffer. Lowering the pH to a value below the pKa of the acidic groups will force the groups to loose their negative charges (by acquiring protons), and thus release the bound polyelectrolytes. Although it is clear from the above discussion that the separation medium can be modified to acquire positive or negative charges by the choice of the functional groups, henceforth, the focus will be on the cases where the separation medium is functionalized with basic groups, to act as nucleic acid purifiers.
- In addition to choosing the condition of binding, in this invention, the pKa of the basic groups is chosen to be near or slightly below neutral pH to avoid the harsh conditions that will be required otherwise to release polyelectrolytes, especially biomolecules. When the pKa is around 5 to 7, then polyelectrolytes can bind at pH 7, as discussed above, and can be eluted by a change of the pH to 8 to 10 (weakly basic). This distinguishes this invention from the prevailing methods of purifying proteins and nucleic acids, which employ harsh unfavorable conditions of high salt concentrations and/or highly alkaline solutions to release bound molecules, particularly in the case of nucleic acids purification.
- The basic group in a particularly preferred embodiment is p(2-chloroethyl) pyridine (4-picolyl chloride), and similar pyridine, quinoline, imidazole, and pyrimidine derivatives, with near neutral pKa, such as 2-ethyl benzimidazole (6.18), 2-methyl benzimidazole (6.19), 2-phenyl benzimidazole (5.23), isoquinoline (5.42), papaverine (6.4), pyrimidine (6.35), phenanthridine (5.58), p-phenitidine (5.20), 2-picoline (5.97), 3-picoline (5.68), 4-picoline (6.02), pilocarpine (6.87), 2-amino pyridine (6.82), 2-benzyl pyridine (5.13), 2,5-diamino pyridine (6.48), 2,3-dimethyl pyridine (6.57), 2,4-dimethyl pyridine (6.99), 3,5-dimethyl pyridine (6.15), 2-ethyl pyridine (5.89), benzimidazole (5.532), quinoline (4.9), 8-hydoroxy quinoline (5.0), 6-methoxy quinoline (5.03), 2-methyl quinoline (5.83), 4-methyl quinoline (5.67), 2-aminothiazole (5.36), p-toluidine (5.08).
- For acidic groups, in a preferred embodiment, the groups are carboxylic or phenolic, having a pKa of about 7. Therefore, at pH=8, ninety percent of the groups will acquire negative charges, and thus bind to positively charged polyelectrolytes. In a preferred embodiment, for example, a positively charged polyelectrolyte binds to the separation medium at pH 7, and is eluted by a buffer solution of pH value of about 5 (weakly acidic).
- The present invention also describes polymeric separation media suitable for implementing purification, by chemically attaching the above mentioned pH-dependent functional groups to such polymeric separation media, as in FIG. 4(A). In preferred embodiments, the polymeric separation medium is one of polysaccharide, silica, or polyacrylamide polymers. The polysaccharide is preferably an agarose, a dextran, or a cyclodextrin, and derivatives thereof. Typical cyclodextrins are the α, β- and γ-cyclodextrins. In a preferred method of purification, the sample containing the nucleic acids to be purified is equilibrated with the polymeric separation medium in particulate form (gel particles) carrying pH-dependent groups at pH near the pKa of the groups, where the nucleic acids can preferentially bind to the gel particles. The particles are allowed to separate from the sample solution by gravitational settling or centrifugation, and the unbound solution is aspirated. The particles are washed with a buffer also having a pH near the pKa of the basic groups, and the wash buffer is again aspirated after separation from the particles. The bound nucleic acids may be eluted by a buffer having pH approximately 3 units higher than the pKa of the basic groups, thus releasing the nucleic acids in pure form.
- In another preferred embodiment, the above polymeric separation medium surrounds a magnetic core, such as paramagnetic iron oxide particles, as described schematically in FIG. 4(B). For example, magnetic particles may be coated by polymers, using techniques known in the art, to form magnetized separation media in particulate form. The polymer may be subsequently functionalized with pH-dependent groups as discussed herein. In another preferred method of purification, the sample containing the nucleic acids to be purified is equilibrated with the magnetized particles carrying basic groups at a pH near or slightly above the pKa of the groups (e.g., pKa=6, and pH˜7), where they preferentially bind nucleic acids. Using a magnet, the particles are separated from the solution. The particles are washed with a buffer, also having a pH near the pKa of the basic groups and the particles are again separated using a magnet, and the wash buffer is aspirated. The bound nucleic acids may be eluted from the particles by a buffer having pH approximately 3 units higher than the pKa of the basic groups, thus releasing the nucleic acids in pure form.
- In another embodiment, the separation medium is a gel that pervades the pores of a porous support to form a continuous phase. The porous support is fabricated into a device for the separation using convective flow. The device is formed by imbibing a dissolved, gellable polymer into the pores of the porous support. In a preferred embodiment, the polymer is dissolved by the use of chaotropes. Chaotropes are small solutes that influence the solution behavior of a solvent and its dissolving power. Chaotropes can give the solution the capacity to dissolve polymers that are normally sparingly soluble in the pure solvent. For example, the polymer is a polysaccharide and the chaotrope is urea, guanidinium salts, or KI. In a preferred embodiment, agarose was dissolved in water solution containing 8M urea. This process yields solutions of agarose, which do not gel at room temperature. If water is carefully added to such a solution, a thin gel layer forms at the interface between the agarose solution and the water. The gel layer prevents the migration of the polysaccharide, but still allows further migration of the much smaller urea molecules. As the urea molecules leave the agarose solution into the mainly water medium, the agarose further gels until all the agarose solution turns into gel. The resulting gel can be further chemically modified to attach the pH-dependent groups described above to be used as a separation medium. This process is schematically depicted in FIG. 1(A) through FIG. 1(D), and further explained in Examples 1 through 3.
- The porous support can take several forms, preferably a cylindrical shape or a flat shape, as shown in FIGS. 2 and 3, respectively. The polysaccharide solution just described is pushed or drawn by vacuum to impregnate the pores of a porous support, and the excess solution is drained off. The chaotrope (urea) is allowed to migrate from the polysaccharide solution by diffusion through the pores of the support when soaking in water. As the concentration of urea in the pores is lowered, the agarose gels in the pores of the support. The agarose thus becomes entrapped in the pores of the support. This gelling process appears to be unique and gives a stable and reproducible pore-size distribution that is useful for the purpose of this invention. The resulting gel in the above process can be further locked inside the pores by cross-linking of the agarose with a cross-linking agent such as epichlorohydrin and 1,2-dibromo propane.
- The porous support material may be made of a number of polymeric, glass, metallic and ceramic materials. In a preferred embodiment, the porous support may be fabricated from ultra high density polyethylene, or polypropylene composition, that is formed into the shape and configuration as shown in FIGS. 2 and 3, which can be obtained from Porex Company, located at Fairburn, Ga.
- In another preferred method of purification, the sample containing the nucleic acids to be purified is passed through polymeric separation medium containing basic groups, formed in the pores of the porous support. The process is carried out where the sample and the polymeric separation medium are equilibrated at a pH near or slightly above the pKa of the groups (e.g., pKa=6, and pH˜7), whereby the nucleic acids bind to the polymeric separation medium. Wash buffer is then flown to wash off unbound solutes. Wash buffers may have the same pH as the binding buffer (˜7). The bound nucleic acids may be eluted by a buffer having pH approximately 3 units higher than the pKa of the basic groups, thus releasing the nucleic acids in substantially pure form.
- 25 grams of agarose (Sigma Chemical Co., St. Louis, Mo., product number A9918) were dissolved in one liter of 8M urea solution by heating the solution with stirring until the solution became clear, forming
layer 12, in FIG. 1. The medium is made by slowly adding water, 11, on top of a 2.5% (W/V) agarose solution in 8M urea, 12. A thin layer of gel, 13, which forms at the interface of the agarose and water layers, grows in thickness until all the agarose gels as time progresses from FIG. 1(A) to FIG. 1(D), and as described in Example 1. This solution remained ungelled after cooling to room temperature for a period of over 150 days. Upon slow addition of water, layer 11 in FIG. 1, to the top of this solution and standing unperturbed for a few hours, a gelled layer, 13, forms at the interface. This is indicated by the appearance of a white color. This layer plays an important role in preventing further mixing of the water with the agarose in the chaotropic solution. Water and urea molecules can cross this layer, but the agarose molecules, being considerably larger, remain in the bottom layer. At longer times, more urea molecules diffused to the top layer, until the whole bottom part became gelled, as shown in FIGS. 1(A) to 1(D). This solution behavior of agarose was repeated with quantities of agarose concentrations varying from 0.5 to 4% (in 8M urea solution). This solution behavior was also reproduced with 3M Nal solution and buffered 8M guanidine hydrochloride solution. The agarose dissolved to form a clear solution that did not gel at room temperature, however, it became yellowish with time in the case of Nal, presumably due to the oxidation of iodide ions. In the devices that were constructed using this approach, a gelled layer is formed at the surface of the porous support, preventing migration of the entrapped polymer from the pores. The gel structure of the entrapped polymer becomes more predictable as a result of this process. - An ultra high molecular weight polyethylene (UHMWPE) porous cylinder, 9.5 mm O.D., 4.8 mm I.D., and 35 mm long was used, with one end sealed and the other open. This cylinder had nominal pore size of 20 microns and void volume (empty space in the walls of the cylinder) of approximately 50%. The inner bore of the cylinder was blocked by a rod of the same diameter as the ID of the cylinder to prevent the agarose solution from filling the bore. Agarose (2.5% w/v) was solubilized in 8M Urea as in Example 1. The agarose solution was vacuum drawn into the pores of the cylinder using a vacuum pump. The cylinder was soaked in water overnight. Referring to the schematic in FIG. 2, this cylinder is numbered21. The agarose gelled in the pores of the cylinder as the urea diffused out to form the gel, 23. The rod was removed from the cylinder. A luer fitting attachment, 24, was sealed to the open end of the cylinder, and was used to attach the device to syringes or peristaltic pumps for the purpose of processing fluids. The device was placed in a casing, 22. The liquid permeability decreased from approximately 1800 for the gel-free device to about 8 after this step, indicating filling of the pores with the gel.
- The agarose-filled cylinder in Example 2 was equilibrated in 1M NaOH for 4 hours. The NaOH was drained out and the agarose was cross-linked using 3% epichlorohydrin in 95% (V/V) ethanol/water mixture for 16 hours at room temperature. The resulting cross-linked gel can be used a filtration device. The liquid permeability of the device after cross-linking increased slightly to about 10.
- The agarose in the cylinder of Examples 3 was allowed to react with 5% (W/V) p-(2-chloroethyl) pyridine (4-picolyl chloride) in 50% (W/V) reagent alcohol-water for 16 hours. This cylinder produced a device with a weak base that is suitable for DNA exchange, since the picolyl group has a pKa of about 6, it can bind DNA at neutral pH's and release DNA at moderately high pH (9).
- The agarose was cross-linked and re-equilibrated in 10% NaOH in a cylinder as in Examples 2-3. The cylinder was then allowed to react with 10% (W/V) chloroacetic acid in 95% (W/V) reagent alcohol-water for 16 hours. This cylinder produced a device with carboxyl group modified agarose as a weak cation exchanger.
- The cylinder in Example 5 was equilibrated with 15 mM Tris buffer at pH=7. Aliquots of 5 ml of cytochrome c at 1 mg/ml in the same buffer were loaded through the wall of the cylinder by closing one end of the cylinder. Total protein bound was 32 mg. The cylinder acquired the color of the protein. The device was washed with buffer, and the protein was eluted using aliquots of 500 mM buffered sodium chloride solution. As in Example 5, FIG. 8 shows the bind-elution histogram for cytochrome c.
- Sephadex G-50 beads (polysaccharide consisting of dextran and cross-linked agarose, Sigma Chemical Co., St, St. Louis, Mo.) were suspended in dioxane and allowed to react with 5% (W/V) p(2-chloroethyl) pyridine (4-picolyl chloride) hydrochloride in 95% (V/V) dioxane-water for 16 hours, with the addition of potassium carbonate as a base. The liquid was aspirated and the beads were washed repeatedly with water until the color disappeared. The beads were functionalized to produce a DNA purifier, since p-ethyl pyridine (gamma picoline) has a pKa of about 6, it can bind DNA at neutral pH's and release DNA at moderately high pH (9). As shown in FIG. 4, the polymeric separation medium may be one of polysaccharide, silica, or other polymers that can be functionalized to attach the groups. These are acid-base groups, and depending on the ambient pH value, the groups can be protonated, as shown (RH), or deprotonated (R). The groups can be a basic nitrogen, which can be protonated (—NH+) for polynucleotide purification, or the groups can be a deprotonated carboxyl (—COO—) or a deprotonated phenolic (—C6H4—O-) for the purification of positively charged proteins. FIG. 4(B) shows a schematic where the polymeric separation medium, 41, surrounds a magnetic core, 42, such as paramagnetic iron oxide.
- Approximately 50 mg of the beads in Example 7 were allowed to equilibrate with 0.3 ml of 30 mM acetate buffer of pH=5.5 in an eppendorf tube. 2 microgram solution of DNA (PBKSRV plasmid, from Strategene, ˜8 kb in length) in 0.05 ml of water were added to the beads and allowed to incubate at room temperature for approximately 10 minutes with mixing. The beads were centrifuged and the supernatant aspirated. The beads were washed three times with 0.5 ml each of the same buffer, centrifuged, and the buffer was aspirated after each wash. An aliquots of 0.2 ml of alkaline (pH=9) solution of HEPES buffer was added to the beads to elute the bound DNA, and the solution was aspirated. Another 0.5 ml elution step was applied, and again the supernatant was aspirated after centrifugation. After each aspiration step, the aspirated solution was saved for later DNA analysis by gel electrophoresis. Gel electrophoresis results indicate binding of the DNA under the acidic conditions and DNA release under the slightly alkaline elution.
- Paramagnetic iron oxide beads coated with silica were treated to produce a DNA purifier in a method similar to that in Example 7, by attaching 4-picoline to the silica separation medium.
- Approximately 50 mg of the magnetic beads in Example 9 were allowed to equilibrate with 0.3 ml of 30 mM acetate buffer of pH=5.5 in an eppendorf tube. 2 microgram solution of the DNA used in Example 8 in 0.05 ml of water were added to the beads and allowed to incubate at room temperature for approximately 10 minutes with mixing. A magnet was brought in contact with the tube, where the magnetic beads were attracted to the side of the tube contacting the magnet, and the supernatant aspirated. The beads were washed three times with 0.5 ml each of the same buffer, and after contacting the tube with the magnet, the buffer was aspirated after each wash. An aliquots of 0.2 ml of alkaline (pH=9) solution of HEPES buffer was added to the beads to elute the bound DNA, mixed and the supernatant aspirated after contacting the tube with the magnet. Another 0.5 ml elution step was applied, and again the supernatant was aspirated after magnetic separation. After each aspiration step, the aspirated solution was saved for analysis. Gel electrophoresis results indicated binding of the DNA under the acidic conditions and complete release of the DNA under the slightly alkaline elution.
- Approximately 50 mg of the magnetic beads in Example 9 were allowed to equilibrate with 0.5 ml of 30 mM acetate buffer of pH=5.5 in an eppendorf tube. 2 microgram solution of DNA in 0.2 ml of calf serum was added to the beads and the procedure in Example 10 was followed. Gel electrophoresis results indicate binding of the DNA under the acidic conditions and complete release of the DNA under the slightly alkaline elution. The released DNA band in this example was slightly diffuse, presumably due to DNA degradation by the action of nucleases present in the serum, a condition that can be avoided by the addition of a protease or other nuclease-deactivating substances.
Claims (17)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/436,813 US20030204067A1 (en) | 1991-10-07 | 2003-05-13 | Materials and methods for the purification of polyelectrolytes, particularly nucleic acids |
US11/555,975 US20070117972A1 (en) | 1991-10-07 | 2006-11-02 | Materials and Methods For the Purification of Polyelectrolytes, Particularly Nucleic Acids |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77234691A | 1991-10-07 | 1991-10-07 | |
US23834399A | 1999-01-27 | 1999-01-27 | |
US09/840,570 US6562573B2 (en) | 1999-01-27 | 2001-04-23 | Materials and methods for the purification of polyelectrolytes, particularly nucleic acids |
US10/436,813 US20030204067A1 (en) | 1991-10-07 | 2003-05-13 | Materials and methods for the purification of polyelectrolytes, particularly nucleic acids |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/840,570 Division US6562573B2 (en) | 1991-10-07 | 2001-04-23 | Materials and methods for the purification of polyelectrolytes, particularly nucleic acids |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/555,975 Continuation US20070117972A1 (en) | 1991-10-07 | 2006-11-02 | Materials and Methods For the Purification of Polyelectrolytes, Particularly Nucleic Acids |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030204067A1 true US20030204067A1 (en) | 2003-10-30 |
Family
ID=22897475
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/840,570 Expired - Fee Related US6562573B2 (en) | 1991-10-07 | 2001-04-23 | Materials and methods for the purification of polyelectrolytes, particularly nucleic acids |
US10/436,813 Abandoned US20030204067A1 (en) | 1991-10-07 | 2003-05-13 | Materials and methods for the purification of polyelectrolytes, particularly nucleic acids |
US11/555,975 Abandoned US20070117972A1 (en) | 1991-10-07 | 2006-11-02 | Materials and Methods For the Purification of Polyelectrolytes, Particularly Nucleic Acids |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/840,570 Expired - Fee Related US6562573B2 (en) | 1991-10-07 | 2001-04-23 | Materials and methods for the purification of polyelectrolytes, particularly nucleic acids |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/555,975 Abandoned US20070117972A1 (en) | 1991-10-07 | 2006-11-02 | Materials and Methods For the Purification of Polyelectrolytes, Particularly Nucleic Acids |
Country Status (4)
Country | Link |
---|---|
US (3) | US6562573B2 (en) |
EP (1) | EP1147226B1 (en) |
AU (1) | AU2862100A (en) |
WO (1) | WO2000044928A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150258469A1 (en) * | 2014-03-13 | 2015-09-17 | Folim G. Halaka | Purification columns and methods |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9425138D0 (en) | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
PT1036082E (en) * | 1997-12-06 | 2002-10-31 | Dna Res Innovations Ltd | ISOLATION OF NUCLEIC ACIDS |
US6914137B2 (en) | 1997-12-06 | 2005-07-05 | Dna Research Innovations Limited | Isolation of nucleic acids |
GB0127809D0 (en) * | 2001-11-20 | 2002-01-09 | Dna Res Innovations Ltd | Purification of nucleic acid |
CA2473376A1 (en) | 2002-01-16 | 2003-07-31 | Dynal Biotech Asa | Method for isolating nucleic acids and protein from a single sample |
GB0212826D0 (en) * | 2002-05-31 | 2002-07-10 | Dna Res Innovations Ltd | Materials and methods relating to polyions and substance delivery |
GB0229287D0 (en) * | 2002-12-16 | 2003-01-22 | Dna Res Innovations Ltd | Polyfunctional reagents |
EP1729882A1 (en) | 2004-02-05 | 2006-12-13 | Millipore Corporation | Porous adsorptive or chromatographic media |
US7959979B2 (en) | 2004-02-05 | 2011-06-14 | Millipore Corporation | Method of forming coated structures |
US7807823B2 (en) | 2004-02-05 | 2010-10-05 | Millipore Corporation | Method of forming polysaccharide structures |
CN100540123C (en) * | 2004-02-05 | 2009-09-16 | 米利波尔公司 | Form the method for coated structure |
WO2005077529A1 (en) * | 2004-02-05 | 2005-08-25 | Millipore Corporation | Porous adsorptive or chromatographic media |
US7687619B2 (en) * | 2004-02-05 | 2010-03-30 | Millipore Corporation | Room temperature stable agarose solutions |
US8481017B2 (en) * | 2004-02-23 | 2013-07-09 | Florida State University Research Foundation, Inc. | Thin films for controlled protein interaction |
KR100647306B1 (en) | 2004-12-23 | 2006-11-23 | 삼성전자주식회사 | 1 Method for isolating a nucleic acid using a material positively charged at the first pH and comprising an amino group and a carboxyl group |
KR100657957B1 (en) | 2005-04-12 | 2006-12-14 | 삼성전자주식회사 | 1 Method for isolating a nucleic acid using a material positively charged at the first pH and comprising an amino group and a carboxyl group and a solid material for a nucleic acid purification capable of being used for the method |
GB0714326D0 (en) * | 2007-07-23 | 2007-08-29 | Univ Sheffield | Adhesive materials |
US9433922B2 (en) * | 2007-08-14 | 2016-09-06 | Emd Millipore Corporation | Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same |
US20090130738A1 (en) * | 2007-11-19 | 2009-05-21 | Mikhail Kozlov | Media for membrane ion exchange chromatography |
US8293742B2 (en) * | 2008-08-01 | 2012-10-23 | Alpha Synergy Development, Inc. | Preferential vasoconstriction compositions and methods of use |
US11235323B2 (en) | 2008-08-27 | 2022-02-01 | Life Technologies Corporation | Apparatus for and method of processing biological samples |
CN102203605B (en) | 2008-08-27 | 2014-07-23 | 生命技术公司 | Apparatus for and method of processing biological samples |
EP2398577A2 (en) * | 2009-02-19 | 2011-12-28 | Bonner, Alex Garfield | Porous interpenetrating polymer network |
GB2473868A (en) | 2009-09-28 | 2011-03-30 | Invitrogen Dynal As | Apparatus and method of automated processing of biological samples |
EP2513335A4 (en) * | 2009-12-14 | 2013-09-11 | Betty Wu | Method and materials for separating nucleic acid materials |
US20120034603A1 (en) | 2010-08-06 | 2012-02-09 | Tandem Diagnostics, Inc. | Ligation-based detection of genetic variants |
US10167508B2 (en) | 2010-08-06 | 2019-01-01 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities |
US20140342940A1 (en) | 2011-01-25 | 2014-11-20 | Ariosa Diagnostics, Inc. | Detection of Target Nucleic Acids using Hybridization |
US11203786B2 (en) | 2010-08-06 | 2021-12-21 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
US8700338B2 (en) | 2011-01-25 | 2014-04-15 | Ariosa Diagnosis, Inc. | Risk calculation for evaluation of fetal aneuploidy |
US10533223B2 (en) | 2010-08-06 | 2020-01-14 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
US20130040375A1 (en) | 2011-08-08 | 2013-02-14 | Tandem Diagnotics, Inc. | Assay systems for genetic analysis |
US20130261003A1 (en) | 2010-08-06 | 2013-10-03 | Ariosa Diagnostics, In. | Ligation-based detection of genetic variants |
US11031095B2 (en) | 2010-08-06 | 2021-06-08 | Ariosa Diagnostics, Inc. | Assay systems for determination of fetal copy number variation |
US10131947B2 (en) | 2011-01-25 | 2018-11-20 | Ariosa Diagnostics, Inc. | Noninvasive detection of fetal aneuploidy in egg donor pregnancies |
US8756020B2 (en) | 2011-01-25 | 2014-06-17 | Ariosa Diagnostics, Inc. | Enhanced risk probabilities using biomolecule estimations |
US9994897B2 (en) | 2013-03-08 | 2018-06-12 | Ariosa Diagnostics, Inc. | Non-invasive fetal sex determination |
US11270781B2 (en) | 2011-01-25 | 2022-03-08 | Ariosa Diagnostics, Inc. | Statistical analysis for non-invasive sex chromosome aneuploidy determination |
JP6074428B2 (en) | 2011-08-19 | 2017-02-01 | アクアサイエンス リミテッド | Protein detection |
US8712697B2 (en) | 2011-09-07 | 2014-04-29 | Ariosa Diagnostics, Inc. | Determination of copy number variations using binomial probability calculations |
US10289800B2 (en) | 2012-05-21 | 2019-05-14 | Ariosa Diagnostics, Inc. | Processes for calculating phased fetal genomic sequences |
WO2014015269A1 (en) | 2012-07-19 | 2014-01-23 | Ariosa Diagnostics, Inc. | Multiplexed sequential ligation-based detection of genetic variants |
US11680080B2 (en) | 2014-03-13 | 2023-06-20 | Folim G. Halaka | Purification columns and methods |
EP3117208A4 (en) | 2014-03-13 | 2018-01-24 | Folim G. Halaka | Purification columns and methods |
CN107112105A (en) | 2014-10-23 | 2017-08-29 | 康宁股份有限公司 | The magnetic nanoparticle of polymer encapsulating |
ES2895153T3 (en) * | 2015-08-17 | 2022-02-17 | Emd Millipore Corp | Agarose Ultrafiltration Membrane Composites for Size-Based Separations |
EP4077663A1 (en) | 2019-12-18 | 2022-10-26 | Life Technologies Corporation | Systems, methods, and devices for automated nucleic acid and protein isolation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4672040A (en) * | 1983-05-12 | 1987-06-09 | Advanced Magnetics, Inc. | Magnetic particles for use in separations |
US5032281A (en) * | 1989-08-09 | 1991-07-16 | Daicel Chemical Industries, Ltd. | Separating membrane and separation method |
US5057426A (en) * | 1986-11-22 | 1991-10-15 | Diagen Institut Fur Molekular-Biologische, Diagnostik Gmbh | Method for separating long-chain nucleic acids |
US5491223A (en) * | 1991-02-28 | 1996-02-13 | Daicel Chemical Industries, Ltd. | Polysaccharide derivative and separating agent |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE328534B (en) * | 1965-08-27 | 1970-09-21 | Astra Ab | |
DE2319495C2 (en) * | 1973-04-17 | 1985-01-10 | Yeda Research And Development Co., Ltd., Rehovot | Method for the selective, reversible binding of biomolecules to an adsorbent in a chromatographic column |
US4335017A (en) | 1975-12-15 | 1982-06-15 | United Kingdom Atomic Energy Authority | Composite materials comprising deformable xerogel within the pores of particulate rigid supports useful in chromatography |
US4055469A (en) * | 1976-12-10 | 1977-10-25 | Eastman Kodak Company | Purification of microbial enzyme extracts using synthetic polyelectrolytes |
US4648975A (en) * | 1983-08-17 | 1987-03-10 | Pedro B. Macedo | Process of using improved silica-based chromatographic supports containing additives |
US4724207A (en) | 1984-02-02 | 1988-02-09 | Cuno Incorporated | Modified siliceous chromatographic supports |
FR2561781A1 (en) * | 1984-03-23 | 1985-09-27 | Inst Nat Sante Rech Med | New phase for affinity chromatography containing a pyridinium, and pyridinium substituted at positions 3 and 4 |
US4752459A (en) | 1985-04-09 | 1988-06-21 | Perrer Duncan S | Preparation of porous bodies |
US4710472A (en) * | 1985-09-25 | 1987-12-01 | The United States Of America As Represented By The Secretary Of The Navy | Magnetic separation device |
FR2600655B1 (en) * | 1986-06-30 | 1988-10-21 | Centre Nat Rech Scient | PROTEIN FRACTION EXTRACTED FROM GROWTH FACTOR ACTIVITIES, OBTAINING AND APPLICATION AS A STIMULATION AND POTENTIALIZING AGENT FOR GROWTH FACTOR ACTIVITIES |
US4843012A (en) * | 1986-09-17 | 1989-06-27 | Genetics Institute, Inc. | Novel composition for nucleic acid purification |
US4935342A (en) * | 1986-12-01 | 1990-06-19 | Syngene, Inc. | Method of isolating and purifying nucleic acids from biological samples |
NO162946C (en) * | 1987-08-21 | 1990-03-14 | Otto Soerensen | DEVICE FOR MAGNETIC SEPARATION OF CELLS. |
US5599667A (en) * | 1987-03-02 | 1997-02-04 | Gen-Probe Incorporated | Polycationic supports and nucleic acid purification separation and hybridization |
US4921805A (en) * | 1987-07-29 | 1990-05-01 | Life Technologies, Inc. | Nucleic acid capture method |
FR2619568B1 (en) * | 1987-08-21 | 1989-07-07 | Centre Nat Rech Scient | POLYSTYRENE-DERIVED POLYMERS, PROCESSES FOR THE PREPARATION THEREOF AND APPLICATIONS THEREOF FOR THE ANALYSIS AND PURIFICATION OF ORGANIC MOLECULES |
US4908318A (en) * | 1987-09-04 | 1990-03-13 | Integrated Genetics, Inc. | Nucleic acid extraction methods |
US5183809A (en) * | 1990-02-15 | 1993-02-02 | The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation | Cyclodextrin polymers and cyclodextrins immobilized on a solid surface |
US5028696A (en) * | 1988-10-28 | 1991-07-02 | Torres Anthony R | Ion exchange and separation method |
US5512439A (en) * | 1988-11-21 | 1996-04-30 | Dynal As | Oligonucleotide-linked magnetic particles and uses thereof |
US5075430A (en) * | 1988-12-12 | 1991-12-24 | Bio-Rad Laboratories, Inc. | Process for the purification of DNA on diatomaceous earth |
SU1638162A1 (en) * | 1989-01-06 | 1991-03-30 | Институт цитологии и генетики СО АН СССР | Method of isolation of reverse transcriptase from escherichia coli |
US5234809A (en) * | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
US5334499A (en) * | 1989-04-17 | 1994-08-02 | Eastman Kodak Company | Methods of extracting, amplifying and detecting a nucleic acid from whole blood or PBMC fraction |
US5124444A (en) * | 1989-07-24 | 1992-06-23 | Microprobe Corporation | Lactam-containing compositions and methods useful for the extraction of nucleic acids |
US5128247A (en) * | 1989-08-14 | 1992-07-07 | Board Of Regents, The University Of Texas System | Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources |
US5433847A (en) * | 1989-11-01 | 1995-07-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Radial flow chromatography |
US5000635A (en) * | 1989-11-17 | 1991-03-19 | The Boeing Company | Spring-loaded outboard side lock |
US5523231A (en) * | 1990-02-13 | 1996-06-04 | Amersham International Plc | Method to isolate macromolecules using magnetically attractable beads which do not specifically bind the macromolecules |
IT1240870B (en) * | 1990-02-14 | 1993-12-17 | Talent | PROCEDURE FOR THE EXTRACTION AND PURIFICATION OF HUMAN GENOMIC DNA |
US5019232A (en) | 1990-06-01 | 1991-05-28 | Minnesota Mining And Manufacturing Company | Medium for electrophoresis |
US5654179A (en) * | 1990-11-14 | 1997-08-05 | Hri Research, Inc. | Nucleic acid preparation methods |
US5204246A (en) * | 1990-12-26 | 1993-04-20 | Pioneer Hi-Bred International, Inc. | Dna isolation method |
AT397510B (en) * | 1991-11-06 | 1994-04-25 | Wimmer Theodor | METHOD FOR PRODUCING FATTY ACID ESTERS OF SHORT-CHAIN ALCOHOLS |
US6051380A (en) * | 1993-11-01 | 2000-04-18 | Nanogen, Inc. | Methods and procedures for molecular biological analysis and diagnostics |
DE4143639C2 (en) * | 1991-12-02 | 2002-10-24 | Qiagen Gmbh | Process for the isolation and purification of nucleic acids |
US5710028A (en) * | 1992-07-02 | 1998-01-20 | Eyal; Nurit | Method of quick screening and identification of specific DNA sequences by single nucleotide primer extension and kits therefor |
GB2284208A (en) * | 1993-11-25 | 1995-05-31 | Pna Diagnostics As | Nucleic acid analogues with a chelating functionality for metal ions |
WO1996006262A1 (en) * | 1994-08-25 | 1996-02-29 | Kabushiki Kaisha Iseki Kaihatsu Koki | Excavator for vertical bores |
US5622822A (en) * | 1994-09-13 | 1997-04-22 | Johnson & Johnson Clinical Diagnostics, Inc. | Methods for capture and selective release of nucleic acids using polyethyleneimine and an anionic phosphate ester surfactant and amplification of same |
US5582988A (en) * | 1994-09-15 | 1996-12-10 | Johnson & Johnson Clinical Diagnostics, Inc. | Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same |
US5434270A (en) * | 1994-09-15 | 1995-07-18 | Eastman Kodak Company | Weakly basic polymerizable monomers and polymers prepared therefrom |
US5705628A (en) * | 1994-09-20 | 1998-01-06 | Whitehead Institute For Biomedical Research | DNA purification and isolation using magnetic particles |
US5652348A (en) * | 1994-09-23 | 1997-07-29 | Massey University | Chromatographic resins and methods for using same |
US5660984A (en) * | 1994-12-09 | 1997-08-26 | Davis; Thomas E. | DNA isolating apparatus comprising a non-porous DNA binding, anion exchange resin and methods of use thereof |
US5631146A (en) * | 1995-01-19 | 1997-05-20 | The General Hospital Corporation | DNA aptamers and catalysts that bind adenosine or adenosine-5'-phosphates and methods for isolation thereof |
US5581349A (en) | 1995-03-27 | 1996-12-03 | Halaka; Folim G. | Method for biological cell and particulate analysis |
ATE205213T1 (en) * | 1995-04-28 | 2001-09-15 | Daiichi Seiyaku Co | PENTACYCLIC COMPOUNDS |
CA2198896A1 (en) * | 1995-07-03 | 1997-01-23 | Peter Theodorus Gerardus Sillekens | A method for determining the integrity of nucleic acid |
US5612473A (en) * | 1996-01-16 | 1997-03-18 | Gull Laboratories | Methods, kits and solutions for preparing sample material for nucleic acid amplification |
US5981735A (en) * | 1996-02-12 | 1999-11-09 | Cobra Therapeutics Limited | Method of plasmid DNA production and purification |
SE9600590D0 (en) * | 1996-02-19 | 1996-02-19 | Pharmacia Biotech Ab | Methods for chromatographic separation of peptides and nucleic acid and new high-affinity ion exchange matrix |
US5916746A (en) * | 1996-05-09 | 1999-06-29 | Kirkegaard & Perry Laboratories, Inc. | Formazan-based immunoassay |
US5981235A (en) * | 1996-07-29 | 1999-11-09 | Promega Corporation | Methods for isolating nucleic acids using alkaline protease |
US5874221A (en) * | 1996-08-28 | 1999-02-23 | The United States Of America As Represented By The Secretary Of Agriculture | Species specific method for the PCR detection of phythophthora |
US6060246A (en) * | 1996-11-15 | 2000-05-09 | Avi Biopharma, Inc. | Reagent and method for isolation and detection of selected nucleic acid sequences |
US5770712A (en) * | 1997-03-14 | 1998-06-23 | Virginia Tech Intellectual Properties, Inc. | Crosslinked hydrogel beads from chitosan |
JP4304348B2 (en) * | 1997-09-22 | 2009-07-29 | 独立行政法人理化学研究所 | DNA isolation method |
DE19743518A1 (en) * | 1997-10-01 | 1999-04-15 | Roche Diagnostics Gmbh | Automated, universally applicable sample preparation method |
US6914137B2 (en) * | 1997-12-06 | 2005-07-05 | Dna Research Innovations Limited | Isolation of nucleic acids |
US6194562B1 (en) * | 1998-04-22 | 2001-02-27 | Promega Corporation | Endotoxin reduction in nucleic acid purification |
US7078224B1 (en) * | 1999-05-14 | 2006-07-18 | Promega Corporation | Cell concentration and lysate clearance using paramagnetic particles |
US6534262B1 (en) * | 1998-05-14 | 2003-03-18 | Whitehead Institute For Biomedical Research | Solid phase technique for selectively isolating nucleic acids |
US6270970B1 (en) * | 1999-05-14 | 2001-08-07 | Promega Corporation | Mixed-bed solid phase and its use in the isolation of nucleic acids |
-
2000
- 2000-01-27 AU AU28621/00A patent/AU2862100A/en not_active Abandoned
- 2000-01-27 WO PCT/US2000/002115 patent/WO2000044928A2/en active Application Filing
- 2000-01-27 EP EP00907058A patent/EP1147226B1/en not_active Expired - Lifetime
-
2001
- 2001-04-23 US US09/840,570 patent/US6562573B2/en not_active Expired - Fee Related
-
2003
- 2003-05-13 US US10/436,813 patent/US20030204067A1/en not_active Abandoned
-
2006
- 2006-11-02 US US11/555,975 patent/US20070117972A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4672040A (en) * | 1983-05-12 | 1987-06-09 | Advanced Magnetics, Inc. | Magnetic particles for use in separations |
US5057426A (en) * | 1986-11-22 | 1991-10-15 | Diagen Institut Fur Molekular-Biologische, Diagnostik Gmbh | Method for separating long-chain nucleic acids |
US5032281A (en) * | 1989-08-09 | 1991-07-16 | Daicel Chemical Industries, Ltd. | Separating membrane and separation method |
US5491223A (en) * | 1991-02-28 | 1996-02-13 | Daicel Chemical Industries, Ltd. | Polysaccharide derivative and separating agent |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150258469A1 (en) * | 2014-03-13 | 2015-09-17 | Folim G. Halaka | Purification columns and methods |
US9486717B2 (en) * | 2014-03-13 | 2016-11-08 | Folim G. Halaka | Purification columns and methods |
Also Published As
Publication number | Publication date |
---|---|
EP1147226A4 (en) | 2005-05-11 |
WO2000044928A2 (en) | 2000-08-03 |
WO2000044928A3 (en) | 2000-12-14 |
EP1147226A2 (en) | 2001-10-24 |
AU2862100A (en) | 2000-08-18 |
EP1147226B1 (en) | 2013-01-23 |
US20070117972A1 (en) | 2007-05-24 |
US20010041795A1 (en) | 2001-11-15 |
US6562573B2 (en) | 2003-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6562573B2 (en) | Materials and methods for the purification of polyelectrolytes, particularly nucleic acids | |
US10816546B2 (en) | Binding a target substance | |
Berensmeier | Magnetic particles for the separation and purification of nucleic acids | |
EP1234832B1 (en) | Isolation of nucleic acids | |
JP2965131B2 (en) | Magnetic carrier for nucleic acid binding and nucleic acid isolation method using the same | |
US20050139537A1 (en) | Negatively charged membrane | |
US20060154247A1 (en) | Methods,compositions and kits for cell separation | |
JP2005533646A (en) | Size exclusion ion exchange particles | |
EP1260595A2 (en) | Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same | |
WO2000050160A9 (en) | Negatively charged membrane | |
Odabaşı et al. | Cibacron Blue F3GA‐attached magnetic poly (2‐hydroxyethyl methacrylate) beads for human serum albumin adsorption | |
US20060030056A1 (en) | Use of magnetic material to fractionate samples | |
JP4976391B2 (en) | Isolation of proteins based on isoelectric point using solid buffer | |
JP4178107B2 (en) | Preparation of polymer particles | |
Sii et al. | Bioseparation using affinity techniques | |
EP0203163A1 (en) | Affinity chromatography using dried calcium alginate-magnetite separation media in a magnetically stabilized fluidized bed | |
US5167812A (en) | Affinity chromatogry using dried calcium alginate-magnetite separation media in a magnetically stabilized fluidized bed | |
US5160626A (en) | Blotting methods using polyaldehyde activated membranes | |
US4992172A (en) | Blotting methods using polyaldehyde activated membranes | |
US5167811A (en) | Affinity chromatography using dried calcium alginate-magnetite separation media in a magnetically stabilized fluidized bed | |
JPWO2004078828A1 (en) | Scavenger for substances having an anionic substituent | |
RU2631934C1 (en) | Sorption composite membrane and bioseparating device for dna extraction | |
CN115058414B (en) | Method for purifying plasmid DNA | |
Zulquarnain | Scale-up of affinity separation based on magnetic support particles | |
US20070207460A1 (en) | Method For Enriching And Stabilising Components Which Contain Dna And Which Are Made Of Biological Materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: INVITROGEN CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HALAKA, FOLIM G.;REEL/FRAME:016841/0092 Effective date: 20050812 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: LIFE TECHNOLOGIES CORPORATION,CALIFORNIA Free format text: MERGER;ASSIGNOR:INVITROGEN CORPORATION;REEL/FRAME:023882/0551 Effective date: 20081121 Owner name: LIFE TECHNOLOGIES CORPORATION, CALIFORNIA Free format text: MERGER;ASSIGNOR:INVITROGEN CORPORATION;REEL/FRAME:023882/0551 Effective date: 20081121 |
|
AS | Assignment |
Owner name: LIFE TECHNOLOGIES CORPORATION, CALIFORNIA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NO 09452626 PREVIOUSLY RECORDED ON REEL 023882 FRAME 0551. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER SHOULD NOT HAVE BEEN RECORDED AGAINST THIS PATENT APPLICATION NUMBER;ASSIGNOR:INVITROGEN CORPORATION;REEL/FRAME:034217/0490 Effective date: 20081121 |